| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/07/1993 | US5243071 2-alkylidene-aminoguanidines and methods of use therefor |
| 09/07/1993 | US5243029 Oncofetal structure of fibronectin |
| 09/07/1993 | US5243027 Method of preparing angiotensin converting enzyme inhibitors |
| 09/07/1993 | US5242947 Use of polyamines as ionic-channel regulating agents |
| 09/07/1993 | US5242909 Anticarcinogenic agents and antitumor agents |
| 09/07/1993 | US5242905 Pharmaceutical compositions for the treatment of psoriasis |
| 09/07/1993 | US5242903 Enzyme inhibitors |
| 09/07/1993 | US5242902 Defensin peptide compositions and methods for their use |
| 09/07/1993 | US5242901 Bisdioxopiperazine compounds for cardiovascular disorders |
| 09/07/1993 | US5242900 Treatment of diabetes using phosphorylated insulin |
| 09/07/1993 | US5242826 Polypeptides for adhering cells to a substrate |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | US5242823 Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen |
| 09/07/1993 | US5242813 Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
| 09/07/1993 | US5242810 Bifunctional inhibitors of thrombin and platelet activation |
| 09/07/1993 | US5242798 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 09/07/1993 | US5242692 Anti-metastatic factor |
| 09/07/1993 | US5242691 Purified milk product from animal maintained in hyperimmunized state |
| 09/07/1993 | US5242688 Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants |
| 09/07/1993 | US5242687 Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells |
| 09/07/1993 | CA1322078C Enzyme inhibitors |
| 09/07/1993 | CA1322077C Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 09/07/1993 | CA1322076C Phosphorus containing peptides |
| 09/07/1993 | CA1322075C Flourine containing renin inhibitors |
| 09/07/1993 | CA1321962C Dental caries preventive preparations and method for preparing said preparations |
| 09/06/1993 | CA2091024A1 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds |
| 09/06/1993 | CA2090957A1 Anti-tumor method and anti-tumor agent |
| 09/05/1993 | WO1993017697A1 Method of delivering therapeutic substances to the brain |
| 09/05/1993 | CA2107558A1 In vivo binding pair pretargeting |
| 09/05/1993 | CA2102519A1 Method of delivering therapeutic substances to the brain |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/03/1993 | CA2090658A1 Formulated medicine for treatment and/or prevention of opportunistic infectious diseases complicated by infection with lentivirus |
| 09/02/1993 | WO1993017337A1 Method for modulating proopiomelanocortin synthesis in a mammal |
| 09/02/1993 | WO1993017125A1 Oligonucleotide modulation of cell growth |
| 09/02/1993 | WO1993017122A1 Protein with novel pharmacological characteristic |
| 09/02/1993 | WO1993017119A2 A 90k tumor-associated antigen, ir-95 |
| 09/02/1993 | WO1993017108A2 Analogous peptides of the internal image of a viral protein |
| 09/02/1993 | WO1993017106A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/02/1993 | WO1993017105A1 Altered antibodies, products and processes relating thereto |
| 09/02/1993 | WO1993017099A1 Protein for inhibiting collagen-stimulated platelet aggregation |
| 09/02/1993 | WO1993017075A1 High concentration homogenized collagen compositions |
| 09/02/1993 | WO1993017047A1 Compositions and methods for the treatment of thermal injury |
| 09/02/1993 | WO1993017046A1 Novel lectinlike substance |
| 09/02/1993 | WO1993017045A1 A novel serum growth factor |
| 09/02/1993 | WO1993017044A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/02/1993 | WO1993017043A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
| 09/02/1993 | WO1993017040A2 Cystic fibrosis transmembrane conductance regulator (cftr) protein |
| 09/02/1993 | WO1993017039A1 Iso-cyclosporin salts |
| 09/02/1993 | WO1993017038A1 Methods of treating diabetes |
| 09/02/1993 | WO1993017037A1 Treatment of acute migraine or cluster headache attacks |
| 09/02/1993 | WO1993017033A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | WO1993017031A2 Nucleic acids encoding dystrophin-associated proteins |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | WO1993016729A1 Antibodies for and treatment to prevent or reduce the severity of xenograft rejection |
| 09/02/1993 | WO1993016725A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |
| 09/02/1993 | WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 09/02/1993 | WO1993016721A1 Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
| 09/02/1993 | WO1993016719A2 Use of platelet derived growth factor in ophthalmic wound healing |
| 09/02/1993 | WO1993016718A1 Hepatoma treatment with somatostatin analogs |
| 09/02/1993 | WO1993016717A1 Method and agents for promoting wound healing |
| 09/02/1993 | WO1993016716A1 Method and composition for inhibiting angiogenesis |
| 09/02/1993 | WO1993016715A1 Fsf-1 and the early detection of fibrosis |
| 09/02/1993 | WO1993016714A1 Tissue irrigating solution |
| 09/02/1993 | WO1993016713A2 Use of muramyl peptide for the treatment of toxicity |
| 09/02/1993 | WO1993016712A1 MUTANT GPIbα FRAGMENTS AND RECOMBINANT EXPRESSION THEREOF |
| 09/02/1993 | WO1993016711A1 Use of injectable biomaterials in the treatment of hemorrhoids |
| 09/02/1993 | WO1993016710A1 PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/02/1993 | WO1993016709A1 Therapeutic domains of von willebrand factor |
| 09/02/1993 | WO1993016688A1 Facilitated oxygen delivery in conjunction with hemodilution |
| 09/02/1993 | WO1993016687A1 Gels for encapsulation of biological materials |
| 09/02/1993 | WO1993016658A1 Use of injectable biomaterials for the repair and augmentation of the anal sphincters |
| 09/02/1993 | WO1993016595A1 Nutritional product for trauma and surgery patients |
| 09/02/1993 | WO1993015112A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 09/02/1993 | DE4231094A1 Treatment of psoriasis and neuro-dermatitis - with vasopressin to correct deficiency in hormone |
| 09/02/1993 | DE4205938A1 New immuno-toxin contg. CD30 monoclonal antibody - is coupled to type 1 ribosome inactivating protein toxin, for selective elimination of CD30 cells, esp. treatment of Hodgkins disease |
| 09/02/1993 | CA2130997A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | CA2130993A1 Use of injectable biomaterials in the treatment of hemorrhoids |
| 09/02/1993 | CA2130802A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | CA2130748A1 Use of platelet derived growth factor in ophthalmic wound healing |
| 09/02/1993 | CA2130264A1 Oligonucleotide modulation of cell growth |
| 09/02/1993 | CA2130182A1 Methods of treating diabetes |
| 09/02/1993 | CA2129987A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | CA2129827A1 Analogous peptides of a viral protein internal image |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
| 09/02/1993 | CA2117489A1 Tissue irrigating solution |
| 09/02/1993 | CA2117480A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/02/1993 | CA2107773A1 Hepatoma treatment with somatostatin analogs |
| 09/01/1993 | EP0557535A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 09/01/1993 | EP0557498A1 Bone-growth-stimulating composition |
| 09/01/1993 | EP0557455A1 Recombinant feline coronavirus s proteins |
| 09/01/1993 | EP0557442A1 Antithrombosis agents |
| 09/01/1993 | EP0557420A1 Method for inducing maturation of myeloid cells with interleukin-5 |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557417A1 Compositions for reducing oxidative injury |
| 09/01/1993 | EP0557406A1 Gamma-turn peptidomimetics as fibrinogen antagonists |
| 09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 09/01/1993 | EP0557319A1 Therapeutic use of fibroblast growth factor. |